Solara Active Pharma Sciences has informed that the Board in its meeting held today approved the appointment of Arun Kumar Baskaran as Chief Financial Officer (CFO) of the Company and designated him as Key Managerial Personnel with effective from March 8, 2024. The details required under Regulation 30 of the Listing Regulations are attached herewith as Annexure –‘A’ In terms of Regulation 30(5) of the Listing Regulations, Arun Kumar Baskaran is also authorized to determine materiality of an event or information for the purpose of making disclosures relating to the Company to the Stock Exchanges.
The above information is a part of company’s filings submitted to BSE.
